Page last updated: 2024-08-23

paroxetine and nortriptyline

paroxetine has been researched along with nortriptyline in 79 studies

Research

Studies (79)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	14 (17.72)	18.2507
2000's	44 (55.70)	29.6817
2010's	20 (25.32)	24.3611
2020's	1 (1.27)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Dansette, PM; Fontana, E; Poli, SM	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H	1
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Lombardo, F; Obach, RS; Waters, NJ	1
Ahman, M; Holmén, AG; Wan, H	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F	1
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Dalvie, D; Loi, CM; Smith, DA	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Kuhs, H; Rolf, LH; Rudolf, GA; Schlake, HP	1
Insel, TR; Winslow, JT	1
Altieri, L; Finkel, MS; Laghrissi-Thode, F; Miller, MC; Mulsant, BH; Pollock, BG	1
Begley, A; Cornes, C; Dew, MA; Frank, E; Hall, M; Houck, PR; Kupfer, DJ; Mazumdar, S; Miller, MD; Mulsant, B; Perel, JM; Reynolds, CF; Shear, MK	1
Bigger, JT; Finkel, MS; Gaffney, A; Gergel, I; Kennedy, JS; Laghrissi-Thode, F; McCafferty, J; Narayan, M; Nelson, JC; Pollock, BG; Roose, SP	1
Houck, PR; Jacobs, S; Miller, MD; Prigerson, HG; Reynolds, CF; Shear, MK; Zygmont, M	1
Ghaemi, SN; Kirkwood, CK	1
Begley, AE; Kirshner, MA; Mazumdar, S; Mulsant, BH; Nebes, R; Pollock, BG; Reynolds, CF	1
Roose, SP; Suthers, KM	1
Gergel, I; Kennedy, JS; Laghrissi-Thode, F; McCafferty, J; Narayan, M; Nelson, JC; Nobler, MS; Pollock, BG; Robin, DW; Roose, S	1
Dew, MA; Green, TD; Houck, PR; Kupfer, DJ; Mazumdar, S; Miller, MD; Mulsant, BH; Pollock, BG; Reynolds, CF	1
Bensasi, S; Houck, PR; Little, JT; Mazumdar, S; Miller, MD; Mulsant, BH; Nebes, RD; Pollock, BG; Reynolds, CF; Stack, J	1
Mulsant, BH; Pollock, BG; Reynolds, CF; Walters, G	1
Roose, SP; Spatz, E	1
Laghrissi-Thode, F; Pollock, BG; Wagner, WR	1
Anthony, JP; Neumaier, JF; Sexton, TJ	1
Haack, M; Hinze-Selch, D; Kraus, T; Kühn, M; Pollmächer, T; Schuld, A; Uhr, M	1
Balon, R; Jampala, VC; Pohl, R; Ramesh, C; Srinivasan, K; Yeragani, VK	1
Begley, AE; Mamo, DC; Miller, MD; Mulsant, BH; Pollock, BG; Reynolds, CF; Stack, JA; Sweet, RA	1
Begley, A; Mazumdar, S; Mulsant, B; Pollock, BG; Stack, J; Weber, E	1
Davis, S; Ferrell, RE; Houck, PR; Kirshner, MA; Kupfer, DJ; Mazumdar, S; Miller, M; Mulsant, BH; Pollock, BG; Reynolds, CF; Stack, JA; Sweet, RA	1
Becker, JT; Butters, MA; Mulsant, BH; Nebes, RD; Pollock, BG; Reynolds, CF; Zmuda, MD	1
Begley, AE; Bump, GM; Dew, MA; Mazumdar, S; Mulsant, BH; Pollock, BG; Reynolds, CF	1
Goicoechea, C; Martín, MI; Ormazábal, MJ; Sánchez, E	1
Aizenstein, H; Butters, MA; Houck, PR; Mulsant, BH; Nebes, RD; Pollock, BG; Reynolds, CF; Zmuda, MD	1
Andersson, K; Bertilsson, L; Härtter, S; Laine, K; Svensson, JO; Tybring, G; Widén, J	1
Butters, MA; Dew, MA; Fabian, TJ; Kroboth, PD; Linares, AM; Mulsant, BH; Pollock, BG; Reynolds, CF; Trottini, M; Zmuda, MD	1
Bensasi, S; Houck, PR; Mazumdar, S; Miller, MD; Mulsant, BH; Nebes, R; Pollock, BG; Reynolds, CF; Stack, J; Sweet, RA	1
Dew, MA; Frank, E; Gildengers, AG; Houck, PR; Kupfer, DJ; Mazumdar, S; Miller, MD; Mulsant, BH; Pollock, BG; Reynolds, CF	1
Jayaraman, A; Pesce, V; Roose, S; Yeragani, VK	1
Begley, A; Frye, RF; Kirshner, M; Miller, MD; Mulsant, BH; Pollock, BG; Reynolds, CF; Solai, LK; Sorisio, D; Sweet, RA	1
Mallavarapu, M; Pesce, V; Radhakrishna, RK; Roose, S; Yeragani, VK	1
Dew, MA; Houck, P; Mulsant, BH; Reynolds, CF; Szanto, K	1
Dew, MA; Houck, P; Lenze, EJ; Mulsant, BH; Pollock, BG; Reynolds, CF; Shear, MK	1
Rao, R; Yeragani, VK	1
Adeoye, OM; Begley, AE; Ferrell, RE; Kirshner, MA; Mulsant, BH; Pollock, BG; Reynolds, CF; Seligman, K	1
Houck, PR; Koru-Sengul, T; Mazumdar, S; Mulsant, BH; Pollock, BG; Reynolds, CF; Tang, G	1
Basinski, J; Begley, A; Dew, MA; Farhi, P; Mulsant, BH; Reynolds, CF; Whyte, EM	1
Aizenstein, HJ; Dew, MA; Gildengers, AG; Greenhouse, J; Houck, PR; Jones, BL; Mulsant, BH; Pollock, BG; Reynolds, CF	1
Hensley, PL	1
Bensasi, S; Houck, PR; Lenze, EJ; Miller, MD; Mulsant, BH; Reynolds, CF; Stack, JA; Tew, JD; Whyte, EM	1
Begley, AE; Dew, MA; Houck, PR; Mazumdar, S; Mulsant, BH; Reynolds, CF; Scott, J; Tang, G	1
Bensasi, S; Dew, MA; Houck, PR; Lenze, EJ; Mulsant, BH; Pollock, BG; Reynolds, CF; Stack, JA; Whyte, EM	1
Alexopoulos, GS	1
Bienfait, K; Buyske, S; Dicke, A; Dobkin, RD; Gara, M; Marin, H; Mark, MH; Menza, M	2
Billups, SJ; Delate, T; Dugan, D	1
Freeman, MP	1
Benedet, J; Carvalho-Silva, M; Jeremias, GC; Quevedo, J; Rezin, GT; Rochi, N; Santos, PM; Scaini, G; Streck, EL	1
Benedet, J; Borges, LS; Gomes, LM; Pezente, DP; Quevedo, J; Rezin, GT; Rochi, N; Santos, PM; Scaini, G; Streck, EL	1
Bienfait, KL; Dicke, A; Dobkin, RD; Gara, M; Marin, H; Mark, MH; Menza, M; Tröster, A	1
Bienfait, KL; Dicke, A; Dobkin, RD; Friedman, J; Gara, M; Marin, H; Mark, MH; Menza, M	1
Baldo, P; Cecco, S; Doree, C; McFerran, D; Molin, P	1
Howard, LM; Karia, AM; McGeown, HR; Molyneaux, E; Trevillion, K	1
Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N	1
Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X	1
Derijks, HJ; Grootens, K; Jessurun, N; Mikes, O; Otten, LS; van Marum, RJ; van Puijenbroek, EP; Vermeulen Windsant, A	1
Carson-Chahhoud, KV; Pollok, J; van Agteren, JE	1
Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA	1
Alsaab, S; Cobb, C; Haidari, M; Mansani, S; Ponds, D; Romero, L	1
Derijks, HJ; Grootens, K; Jessurun, NT; Mikes, O; van Marum, RJ; van Puijenbroek, EP; Vermeulen Windsant, A	1

Reviews

10 review(s) available for paroxetine and nortriptyline

Article	Year
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity. Current drug metabolism, 2005, Volume: 6, Issue:5 Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic	2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Antidepressant response in late-life depression. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 10 Topics: 1-Naphthylamine; Age Factors; Aged; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Middle Aged; Nortriptyline; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1998
Treatment of depression in patients with heart disease. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Comorbidity; Death, Sudden; Depressive Disorder; Double-Blind Method; Heart Block; Heart Diseases; Humans; Hypotension, Orthostatic; Myocardial Ischemia; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ventricular Fibrillation	1999
Treatment of bereavement-related depression and traumatic grief. Journal of affective disorders, 2006, Volume: 92, Issue:1 Topics: Antidepressive Agents, Tricyclic; Bereavement; Depressive Disorder, Major; Humans; Nortriptyline; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic	2006
Antidepressants for patients with tinnitus. The Cochrane database of systematic reviews, 2012, Sep-12, Issue:9 Topics: Amitriptyline; Antidepressive Agents; Depression; Humans; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tinnitus; Trazodone; Trimipramine	2012
Antidepressant treatment for postnatal depression. The Cochrane database of systematic reviews, 2014, Sep-11, Issue:9 Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depression, Postpartum; Female; Fluoxetine; Humans; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2014
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet (London, England), 2016, Aug-27, Volume: 388, Issue:10047 Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride	2016
Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. The Cochrane database of systematic reviews, 2018, 12-19, Volume: 12 Topics: Antidepressive Agents, Tricyclic; Depression; Dizziness; Dyspnea; Exercise Tolerance; Forced Expiratory Volume; Humans; Nausea; Nortriptyline; Paroxetine; Placebos; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2018
Antidepressant pharmacogenetics in children and young adults: A systematic review. Journal of affective disorders, 2019, 07-01, Volume: 254 Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult	2019

Trials

32 trial(s) available for paroxetine and nortriptyline

Article	Year
Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline. Acta psychiatrica Scandinavica, 1992, Volume: 85, Issue:5 Topics: Adult; Amitriptyline; Antidepressive Agents; Blood Platelets; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Receptors, Serotonin; Serotonin; Serotonin Antagonists	1992
Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients. Psychopharmacology bulletin, 1995, Volume: 31, Issue:4 Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Nortriptyline; Paroxetine; Posture; Psychiatric Status Rating Scales	1995
High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression. The American journal of psychiatry, 1996, Volume: 153, Issue:11 Topics: Age Factors; Age of Onset; Aged; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Lithium; Male; Nortriptyline; Paroxetine; Perphenazine; Placebos; Psychotherapy; Recurrence; Risk Factors; Treatment Outcome	1996
Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA, 1998, Jan-28, Volume: 279, Issue:4 Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Heart Function Tests; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	1998
A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:5 Topics: Adjustment Disorders; Adult; Aged; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; Female; Grief; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome	1998
Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline. The American journal of psychiatry, 1998, Volume: 155, Issue:8 Topics: Aged; Cholinergic Antagonists; Depressive Disorder; Humans; Nortriptyline; Paroxetine; Radioligand Assay; Receptors, Muscarinic; Tachycardia; Xerostomia	1998
Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. The American journal of psychiatry, 1999, Volume: 156, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1999
Accelerating antidepressant response in geriatric depression: a post hoc comparison of combined sleep deprivation and paroxetine versus monotherapy with paroxetine, nortriptyline, or placebo. Journal of geriatric psychiatry and neurology, 1999,Summer, Volume: 12, Issue:2 Topics: Aged; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Geriatric Psychiatry; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Deprivation	1999
A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20 Topics: Age Factors; Age of Onset; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1999
Continuation and maintenance pharmacotherapy in geriatric depression: an open-trial comparison of paroxetine and nortriptyline in patients older than 70 years. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20 Topics: Age Factors; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Nortriptyline; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1999
Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; beta-Thromboglobulin; Coronary Disease; Depressive Disorder; Double-Blind Method; Humans; Nortriptyline; Paroxetine; Platelet Activation; Platelet Aggregation; Platelet Factor 4	2000
Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2000,Summer, Volume: 8, Issue:3 Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2000
Weight change in older depressed patients during acute pharmacotherapy with paroxetine and nortriptyline: a double-blind randomized trial. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2000,Summer, Volume: 8, Issue:3 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Body Weight; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Weight Gain; Weight Loss	2000
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 23, Issue:5 Topics: Adrenergic alpha-Agonists; Aged; Alleles; Antidepressive Agents, Tricyclic; Carrier Proteins; Depressive Disorder; Double-Blind Method; Female; Genotype; Humans; Lymphocytes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Norepinephrine; Nortriptyline; Paroxetine; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins	2000
Changes in cognitive functioning following treatment of late-life depression. The American journal of psychiatry, 2000, Volume: 157, Issue:12 Topics: Aged; Antidepressive Agents; Cognition Disorders; Comorbidity; Dementia; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Treatment Outcome	2000
Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly. Depression and anxiety, 2001, Volume: 13, Issue:1 Topics: Adrenergic Uptake Inhibitors; Aged; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Time Factors	2001
Dual-task performance in depressed geriatric patients. Psychiatry research, 2001, Jun-01, Volume: 102, Issue:2 Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Geriatric Assessment; Humans; Nortriptyline; Paroxetine; Remission Induction; Task Performance and Analysis; Visual Perception	2001
Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test. Clinical pharmacology and therapeutics, 2001, Volume: 70, Issue:4 Topics: Adult; Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Debrisoquin; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Mixed Function Oxygenases; Nortriptyline; Paroxetine; Phenotype; Tremor; Xerostomia	2001
Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults. Biological psychiatry, 2001, Nov-15, Volume: 50, Issue:10 Topics: Aged; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydrocortisone; Male; Middle Aged; Nortriptyline; Paroxetine; Personality Inventory; Treatment Outcome	2001
A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2001,Fall, Volume: 9, Issue:4 Topics: Aged; Alzheimer Disease; Antidepressive Agents, Tricyclic; Depression; Double-Blind Method; Female; Humans; Male; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors	2001
Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures. Biological psychiatry, 2002, Sep-01, Volume: 52, Issue:5 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Depressive Disorder, Major; Electrocardiography, Ambulatory; Fractals; Heart Rate; Humans; Middle Aged; Myocardial Ischemia; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Signal Processing, Computer-Assisted; Sleep; Wakefulness	2002
Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients. Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:5 Topics: Adrenergic Agents; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP2D6; Debrisoquin; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nortriptyline; Paroxetine; Time Factors	2002
Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate. Neuropsychobiology, 2002, Volume: 46, Issue:3 Topics: Aged; Analysis of Variance; Antidepressive Agents; Depressive Disorder, Major; Discriminant Analysis; Heart Rate; Humans; Middle Aged; Models, Cardiovascular; Myocardial Ischemia; Nonlinear Dynamics; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Time Factors	2002
Occurrence and course of suicidality during short-term treatment of late-life depression. Archives of general psychiatry, 2003, Volume: 60, Issue:6 Topics: Aged; Combined Modality Therapy; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Nortriptyline; Paroxetine; Psychotherapy; Risk Factors; Severity of Illness Index; Suicide; Suicide, Attempted; Time Factors; Treatment Outcome	2003
Good treatment outcomes in late-life depression with comorbid anxiety. Journal of affective disorders, 2003, Volume: 77, Issue:3 Topics: Age of Onset; Aged; Aged, 80 and over; Aging; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Combined Modality Therapy; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Middle Aged; Nortriptyline; Paroxetine; Patient Dropouts; Prognosis; Psychotherapy; Treatment Outcome	2003
Estimating treatment effects from longitudinal clinical trial data with missing values: comparative analyses using different methods. Psychiatry research, 2004, Dec-15, Volume: 129, Issue:2 Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cognition Disorders; Data Interpretation, Statistical; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Paroxetine; Reference Values; Research Design; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome	2004
Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:12 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2004
Impact of prior treatment exposure on response to antidepressant treatment in late life. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2006, Volume: 14, Issue:11 Topics: Aged; Antidepressive Agents, Second-Generation; Bupropion; Combined Modality Therapy; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium Carbonate; Long-Term Care; Male; Nortriptyline; Paroxetine; Psychotherapy; Retreatment; Treatment Failure; Treatment Outcome	2006
A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology, 2009, Mar-10, Volume: 72, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Cognition; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Parkinson Disease; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sleep; Social Behavior; Treatment Outcome	2009
The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, Jul-15, Volume: 24, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depression; Disability Evaluation; Double-Blind Method; Female; Humans; Male; Middle Aged; Nortriptyline; Parkinson Disease; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Recurrence; Treatment Outcome	2009
The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences, 2010,Spring, Volume: 22, Issue:2 Topics: Adult; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cognition Disorders; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Parkinson Disease; Paroxetine; Time Factors; Treatment Outcome	2010
Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2011, Volume: 19, Issue:3 Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Nortriptyline; Parkinson Disease; Paroxetine; Placebos; Psychiatric Status Rating Scales	2011

Other Studies

37 other study(ies) available for paroxetine and nortriptyline

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19 Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats	2007
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2 Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution	2011
Species independence in brain tissue binding using brain homogenates. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7 Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Which metabolites circulate? Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5 Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Serotonergic and catecholaminergic reuptake inhibitors have opposite effects on the ultrasonic isolation calls of rat pups. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1990, Volume: 3, Issue:1 Topics: Animals; Body Temperature; Catecholamines; Citalopram; Clomipramine; Desipramine; Flumazenil; Mazindol; Motor Activity; Naltrexone; Nortriptyline; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Stress, Psychological; Ultrasonics; Vocalization, Animal	1990
Elevation of nortriptyline plasma levels after cotreatment with paroxetine and thioridazine. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Thioridazine	1998
Antidepressant-induced regulation of 5-HT(1b) mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation. Journal of neuroscience research, 2000, Jul-01, Volume: 61, Issue:1 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Autoreceptors; Fluoxetine; Gene Expression; In Situ Hybridization; Male; Nortriptyline; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; RNA, Messenger; Sertraline	2000
Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 23, Issue:1 Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Female; Humans; Leptin; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Nortriptyline; Paroxetine; Receptors, Leptin; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha	2000
Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder. Depression and anxiety, 2000, Volume: 11, Issue:3 Topics: Adult; Antidepressive Agents, Tricyclic; Death, Sudden, Cardiac; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Nortriptyline; Panic Disorder; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors	2000
Salmon calcitonin potentiates the analgesia induced by antidepressants. Pharmacology, biochemistry, and behavior, 2001, Volume: 68, Issue:1 Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Analgesics; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Brain Chemistry; Calcitonin; Depression; Dose-Response Relationship, Drug; Drug Synergism; Hydroxyindoleacetic Acid; Male; Mice; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming	2001
Course and rate of antidepressant response in the very old. Journal of affective disorders, 2002, Volume: 69, Issue:1-3 Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Regression Analysis; Time Factors	2002
Effect of nortriptyline and paroxetine on measures of chaos of heart rate time series in patients with panic disorder. Journal of psychosomatic research, 2003, Volume: 55, Issue:6 Topics: Adult; Antidepressive Agents, Tricyclic; Arousal; Autonomic Nervous System; Electrocardiography; Female; Heart; Heart Rate; Humans; Long QT Syndrome; Male; Nonlinear Dynamics; Nortriptyline; Panic Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Signal Processing, Computer-Assisted	2003
alpha1-acid glycoprotein in late-life depression: relationship to medical burden and genetics. Journal of geriatric psychiatry and neurology, 2003, Volume: 16, Issue:4 Topics: Aged; Aged, 80 and over; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cognition Disorders; Cost of Illness; Depressive Disorder, Major; Double-Blind Method; Female; Gene Expression; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Orosomucoid; Paroxetine; Severity of Illness Index; Surveys and Questionnaires	2003
Trajectories of treatment response in late-life depression: psychosocial and clinical correlates. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:4 Suppl 1 Topics: Age Factors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Humans; Logistic Models; Male; Middle Aged; Nortriptyline; Paroxetine; Psychological Tests; Psychotherapy; Socioeconomic Factors; Treatment Outcome	2005
Statistical analysis of longitudinal psychiatric data with dropouts. Journal of psychiatric research, 2007, Volume: 41, Issue:12 Topics: Antidepressive Agents; Clinical Trials as Topic; Depression; Humans; Likelihood Functions; Longitudinal Studies; Mental Disorders; Nortriptyline; Paroxetine; Patient Dropouts; Randomized Controlled Trials as Topic; Regression Analysis	2007
Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. The American journal of psychiatry, 2007, Volume: 164, Issue:6 Topics: Age Factors; Aged; Antidepressive Agents; Bupropion; Combined Modality Therapy; Depressive Disorder, Major; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium Compounds; Male; Nortriptyline; Paroxetine; Psychotherapy; Secondary Prevention; Time Factors; Treatment Outcome	2007
Personalizing the care of geriatric depression. The American journal of psychiatry, 2008, Volume: 165, Issue:7 Topics: Aged; Alzheimer Disease; Antidepressive Agents, Tricyclic; Brain; Case Management; Comorbidity; Depressive Disorder, Major; Health Services for the Aged; Humans; Magnetic Resonance Imaging; Nortriptyline; Paroxetine; Patient-Centered Care; Psychology; Selective Serotonin Reuptake Inhibitors; Socioeconomic Factors	2008
Evaluation of risk factors for elevated tricyclic antidepressant plasma concentrations. Pharmacoepidemiology and drug safety, 2009, Volume: 18, Issue:3 Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Case-Control Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sex Factors	2009
An imperfect literature and evidence-based medicine. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:3 Topics: Abnormalities, Drug-Induced; Aged, 80 and over; Antidepressive Agents, Second-Generation; Depression, Postpartum; Evidence-Based Medicine; Female; Humans; Nortriptyline; Paroxetine; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Review Literature as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior	2009
Brain creatine kinase activity is increased by chronic administration of paroxetine. Brain research bulletin, 2009, Dec-16, Volume: 80, Issue:6 Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Corpus Striatum; Creatine Kinase, BB Form; Cyclohexanols; Hippocampus; Male; Nortriptyline; Paroxetine; Prefrontal Cortex; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2009
Evaluation of Krebs cycle enzymes in the brain of rats after chronic administration of antidepressants. Brain research bulletin, 2010, May-31, Volume: 82, Issue:3-4 Topics: Animals; Antidepressive Agents; Brain; Citrate (si)-Synthase; Citric Acid Cycle; Cyclohexanols; Male; Nortriptyline; Paroxetine; Rats; Rats, Wistar; Succinate Dehydrogenase; Venlafaxine Hydrochloride	2010
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Journal of affective disorders, 2015, Jul-15, Volume: 180 Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2015
Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels - a review of routine practice. British journal of clinical pharmacology, 2017, Volume: 83, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Cytochrome P-450 CYP2D6 Inhibitors; Depression; Drug Interactions; Female; Humans; Middle Aged; Nortriptyline; Paroxetine	2017
Storage of urine specimens in point of care (POC) urine drug testing cups reduces concentrations of many drugs. Clinica chimica acta; international journal of clinical chemistry, 2019, Volume: 499 Topics: Amitriptyline; Chromatography, Liquid; Drug Storage; Fentanyl; Flunitrazepam; Fluoxetine; Humans; Mass Spectrometry; Nortriptyline; Paroxetine; Point-of-Care Testing; Sertraline	2019
Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels-A prospective pharmacokinetic study. British journal of clinical pharmacology, 2021, Volume: 87, Issue:3 Topics: Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Humans; Nortriptyline; Paroxetine; Prospective Studies	2021